Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Br J Haematol. 2017 Aug 18;179(3):488–496. doi: 10.1111/bjh.14902

Table II.

Deauville 5-point score and freedom from progression for early-stage Hodgkin lymphoma patients selected to receive ABVD and RT (n = 174)

Deauville 5-Point Score n (% cohort) Events 5-Year FFP (95% CI) Log-Rank P
1–2 98 (56%) 0 100% P < 0.001
3 65 (37%) 2 97% (92–100%)
4 8 (5%) 1 83% (53–100%)
5 3 (2%) 1 67% (13–100%)

FFP = freedom from progression

95% CI = 95% confidence interval